Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Asterias Biotherapeutics Inc (AST)  
$0.95 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 49,950,000
Market Cap: 47.20(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.945 - $0.945
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile  


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 108
  Page 2 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Mulroy Michael H. President and CEO   •       •      –    2018-03-15 4 A $0.00 $0 D/D 94,872 107,060     -
   Mulroy Michael H. President and CEO   •       •      –    2018-01-25 4 AB $2.34 $5,000 D/D 2,134 9,933     -
   Mulroy Michael H. President and CEO   •       •      –    2017-12-26 4 AB $2.22 $4,988 D/D 2,247 7,799     -
   Mulroy Michael H. President and CEO   •       •      –    2017-11-27 4 AB $2.41 $5,003 D/D 2,076 5,552     -
   Mulroy Michael H. President and CEO   •       •      –    2017-10-25 4 AB $2.55 $4,944 D/D 1,939 3,476     -
   Bradsher Neal C See Remarks Section   –       –      –    2017-10-16 4 B $0.00 $0 I/I 0 5,292,156 0.01     -
   Bradsher Neal C See Remarks Section   –       –      –    2017-10-16 4 B $2.60 $4,140,001 D/D 1,592,308 5,292,156 2.44     -
   Mulroy Michael H. President and CEO   •       •      –    2017-09-25 4 AB $3.25 $4,997 D/D 1,537 1,537     -
   Lebkowski Jane Chief Scientific Officer   •       •      –    2017-06-05 4 D $3.20 $22,448 D/D (7,015) 102,991     -
   Wirth Edward Chief Medical Officer   •       •      –    2017-06-05 4 D $3.20 $21,584 D/D (6,745) 85,177     -
   Spink Katharine E. EVP & COO   •       •      –    2017-06-05 4 D $3.20 $23,232 D/D (7,260) 10,949     -
   Lebkowski Jane President of R&D   •       •      –    2017-03-30 4 A $0.00 $0 D/D 75,000 110,006     -
   Lebkowski Jane President of R&D   •       •      –    2017-03-30 4 A $0.00 $0 D/D 17,670 35,006     -
   Wirth Edward Chief Medical Officer   •       •      –    2017-03-30 4 A $0.00 $0 D/D 75,000 91,922     -
   Wirth Edward Chief Medical Officer   •       •      –    2017-03-30 4 A $0.00 $0 D/D 16,922 16,922     -
   Spink Katharine E. Chief Operating Officer   •       •      –    2017-03-30 4 A $0.00 $0 D/D 18,209 18,209     -
   Chavez Ryan Daniel CFO and General Counsel   •       •      –    2017-03-30 4 A $0.00 $0 D/D 75,000 84,565     -
   Chavez Ryan Daniel CFO and General Counsel   •       •      –    2017-03-30 4 A $0.00 $0 D/D 9,565 9,565     -
   Cartt Stephen Lahue President and CEO   •       •      –    2017-03-30 4 A $0.00 $0 D/D 32,783 292,783     -
   Spink Katharine E. Chief Operating Officer   •       •      –    2017-01-09 4 AS $4.60 $22,007 D/D (4,781) 0     -
   Spink Katharine E. Chief Operating Officer   •       •      –    2017-01-09 4 D $0.00 $0 D/D (2,878) 4,781     -
   Lebkowski Jane President of R&D   •       •      –    2017-01-09 4 D $0.00 $0 D/D (2,537) 17,336     -
   Spink Katharine E. Chief Operating Officer   •       •      –    2016-12-27 4 AS $5.00 $12,500 D/D (2,500) 0     -
   Spink Katharine E. Chief Operating Officer   •       •      –    2016-12-27 4 OE $2.34 $5,850 D/D 2,500 2,500     -
   Wirth Edward Chief Medical Officer   •       •      –    2016-12-27 4 AS $5.00 $12,500 D/D (2,500) 0     -

  108 Records found
  1  2  3  4  5   
  Page 2 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed